Follow $LSTA

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $LSTA by email
NASDAQ NMS - GLOBAL MARKET · LSTA
-1.14% · -$0.0200 · Vol 184.3K
Market closed · last close 4:00 PM ET · price as of 17:40:24 ET
Lisata Therapeutics Inc

Lisata Therapeutics Inc

Biotechnology
$1.74
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
LSTA
Lisata Therapeutics Inc
Tue Aug 25 · last completed session · Markets closed · resumes Wed 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

58/ 100
Veridion Score
NEUTRAL · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Tue Aug 25 · last completed session · Markets closed · resumes Wed 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is LSTA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading LSTA catalysts
About Lisata Therapeutics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
1999
Employees
21
Country
US

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.75
Day high
$1.90
Day low
$1.72
Previous close
$1.76
52W high
$5.04
-65.48% from high
52W low
$0.9900
19% of range
Market cap
$15.9M
EPS
$-1.8500
Beta
-0.86
Shares out
9M
Volume
184.3K
0.48× rel vol
Avg volume
384K
VWAP
$1.78
Price history computed in-house
1W
+55.36%
1M
+20.83%
3M
-47.27%
1Y
-30.68%
YTD
-6.45%
SMA 50 $2.35 · below
SMA 200 $3.15 · below
52W position 19%

LSTA overview

Veridion Score
58
Registered · 2026-08-25
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around LSTA.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading LSTA Form 4 filings
Public disclosures

Congress activity in LSTA

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for LSTA in the cached public ledger.

Federal contracts

LSTA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for LSTA in this window.
Lobbying spend

LSTA lobbying filings, year to date.

Registered lobbying filings matched to Lisata Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for LSTA in this window.
Loading news for LSTA
Analyst ratings
Sovereign unlock shows live analyst consensus for LSTA.
Options
Sovereign unlock shows live options positioning for LSTA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.